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Differential vulnerability between Substantia Nigra pars compacta (SNpc) and Ventral
Tegmental Area (VTA) dopaminergic (DAergic) neurons is a hallmark of Parkinson’s
disease (PD). Understanding the molecular bases of this key histopathological
aspect would foster the development of much-needed disease-modifying therapies.
Non-heterogeneous DAergic degeneration is present in both toxin-based and genetic
animal models, suggesting that cellular specificity, rather than causing factors,
constitutes the background for differential vulnerability. In this regard, we previously
demonstrated that MPP+, a neurotoxin able to cause selective nigrostriatal degeneration
in animal rodents and primates, inhibits the Hyperpolarization-activated current (Ih) in
SNpc DAergic neurons and that pharmacological Ih antagonism causes potentiation
of evoked Excitatory post-synaptic potentials (EPSPs). Of note, the magnitude of
such potentiation is greater in the SNpc subfield, consistent with higher Ih density.
In the present work, we show that Ih block-induced synaptic potentiation leads to
the amplification of somatic calcium responses (SCRs) in vitro. This effect is specific
for the SNpc subfield and largely mediated by L-Type calcium channels, as indicated
by sensitivity to the CaV 1 blocker isradipine. Furthermore, Ih is downregulated by
low intracellular ATP and determines the efficacy of GABAergic inhibition in SNpc
DAergic neurons. Finally, we show that stereotaxic administration of Ih blockers
causes SNpc-specific neurodegeneration and hemiparkinsonian motor phenotype
in rats. During PD progression, Ih downregulation may result from mitochondrial
dysfunction and, in concert with PD-related disinhibition of excitatory inputs, determine
a SNpc-specific disease pathway.
Keywords: HCN channels, voltage-dependent calcium channels, patch clamp electrophysiology, excitotoxicity,
Parkinson disease, differential vulnerability, mitochondria, dopaminergic neurons
INTRODUCTION
Non-homogeneous degeneration within midbrain dopaminergic (DAergic) neurons is a
histopathological hallmark of Parkinson’s disease (PD). Typically, DAergic neurons in the
Substantia Nigra pars compacta (SNpc) are markedly more vulnerable than in the adjacent
ventral tegmental area (VTA; Schapira, 2011; Brichta and Greengard, 2014). Numerous animal
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models, both toxin-based or transgenic, show non-uniform
DAergic degeneration patterns, strongly suggesting that intrinsic
cellular properties, rather than etiologic factors, underlie
differential vulnerability between distinct subsets (Blesa and
Przedborski, 2014). For therapeutic prospects, understanding
the molecular bases of this key pathogenic feature would
dramatically improve our chances to develop neuroprotective,
disease-modifying treatments. Comparative SNpc-VTA gene
expression studies have revealed extensively overlapping
signatures between the two DAergic populations (Grimm et al.,
2004; Greene et al., 2005), suggesting that quantitative, rather
than qualitative differences in the expression or function of
a limited number of genes subtend selective vulnerability.
Over the last decade, it has been suggested that intrinsic
electrophysiological properties of specific DAergic subsets, such
as the differential expression or function of selected ion channels,
provide a physiological substrate for differential vulnerability
(Liss et al., 2005; Guzman et al., 2009, 2010; Surmeier et al.,
2012; Dryanovski et al., 2013; Dragicevic et al., 2015). In this
regard, we previously demonstrated that MPP+, a neurotoxin
able to cause selective nigrostriatal degeneration in animal
rodents and primates, inhibits the Hyperpolarization-activated
current (Ih) in SNpc DAergic neurons (Masi et al., 2013) and
that pharmacological Ih inhibition causes potentiation of evoked
Excitatory post-synaptic potentials (EPSPs) preferentially in
the SNpc (Masi et al., 2015). The role of Ih in nerve cell
physiology has been extensively studied (He et al., 2014).
Aberrant Ih function alters intrinsic and synaptic excitability
in central and peripheral neurons, leading to the induction
of epileptic states (DiFrancesco et al., 2011; DiFrancesco and
DiFrancesco, 2015) or pathological pain signaling (Emery et al.,
2012; Resta et al., 2016). The implications of Ih dysfunction
in pathological states of the nervous system has prompted the
quest for selective, subunit-specific modulators (Del Lungo
et al., 2012; Novella Romanelli et al., 2016). In midbrain
DAergic neurons, Ih has been the object of deep molecular
and electrophysiological characterization (Mercuri et al., 1995;
Seutin et al., 2001; Neuhoff et al., 2002; Lammel et al., 2008;
Dufour et al., 2014; Krashia et al., 2017), but its implication in
diseases of the DAergic system has remained largely unexplored.
In the present work, we demonstrate that potentiation of
synaptic excitability resulting from Ih inhibition leads to the
amplification of somatic calcium responses (SCRs). The effect
is specific for the SNpc subfield and largely, but not solely,
mediated by L-Type calcium channels. We then show that Ih
is downregulated in presence of low intracellular ATP and
that Ih suppression reduces the inhibitory effect of GABAergic
transmission, suggesting the existence of a mechanistic link
between disruption of mitochondrial homeostasis and abnormal
synaptic excitability in SNpc DAergic neurons. Finally, we tested
the effect of Ih suppression in vivo and found that intracerebral
stereotaxic injection of the selective blockers ivabradine or
ZD7288 causes a pattern of DAergic degeneration strikingly
resembling that seen in MitoPark mice and MPP+-treated mice,
two distinct PD models characterized by mitochondrial failure
and SNpc-specific DAergic degeneration (Ekstrand et al., 2007;
Blesa and Przedborski, 2014). Overall, the present data support
the hypothesis that Ih loss of function may represent a bona
fide pathogenic mechanism in PD and thus a potential target
for the future development of disease-modifying therapeutic
interventions.
MATERIALS AND METHODS
Midbrain Slice Preparation and
Electrophysiological Recordings
All procedures required for ex vivo experiments were conducted
in compliance with the Council Directive of the European
Community (2010/63/EU), Decreto Legislativo Italiano 26
(13/03/2014) and approved by the Animal Care Committee of
the Department of Neurofarba, University of Florence. Wistar
rats of either sex at postnatal day 20–30, were anesthetized with
isoflurane and decapitated. Midbrain horizontal slices (250 µm)
were cut with a vibroslicer (VT1200S; Leica Microsystems Inc.,
IL, USA) in chilled artificial Cerebral Spinal Fluid (aCSF),
composed of (in mM) 130 NaCl, 3.5 KCl, 1.25 NaH2PO4,
25 NaHCO3, 10 glucose, 2 CaCl2 and 1 MgSO4 and saturated
with a 95% O2 + 5% CO2 gas mixture. For electrophysiological
recordings, pipettes were filled with the following whole-cell
solution (in mM): K+ Methanesulfonate (120), KCl (15), HEPES
(10), EGTA (0.1), MgCl2, (2), Na2PhosphoCreatine (5), Na2GTP
(0.3), MgATP (2), resulting in a bath resistance of 2–3 MΩ.
For coupled recordings of electrical and optical signals, 0.1 mM
of Fluo 4 pentapotassium salt was added. Recordings were
performed at 34◦C. Membrane potential values were corrected
for measured junction potential (8 mV) offline. Signals were
sampled at 10 kHz and low-pass filtered at 3 kHz with an
Axon Multiclamp 700B (Molecular Devices, Sunnyvale, CA,
USA). Single or multiple EPSPs were elicited every 15 s
(10 pulses at 10 Hz or 40 pulses at 20 Hz; 5–15 V amplitude).
Stimuli were delivered with a bipolar tungsten electrode (FHC,
Bowdoin, ME, USA), placed at ∼200 µm from the soma of
the recorded neuron or in the substantia nigra pars reticulata
(SNr) for recordings of evoked GABA-mediated Inhibitory
Post-Synaptic Potentials (IPSPs). During EPSP recordings,
neurons were moderately hyperpolarized (∼−2/−3 mV) in
order to stabilize the membrane potential and hamper the
generation of spontaneous or synaptic-driven action potentials
(APs). To monitor pharmacological block, Ih-mediated sag
potential was elicited by imposing short current pulses (−100 pA,
500 ms) at the end of the sweep. MultiEPSP summation
was expressed as the ratio of 10th/1st EPSP amplitude and
multiEPSP area was reported as mV × ms. In voltage
clamp recordings, access resistance was monitored for the
entire duration of the experiment with brief test pulses
(−10 mV, 500 ms). Recordings undergoing a drift in access
resistance ≥10% were discarded. No whole-cell compensation
was used. Ih activation curves were obtained by measuring
the amplitude of tail currents at −115 mV following a
sequence of 4 s-long test pulses from −45 mV to −125 mV.
Electrophysiological and optical traces shown in figures are
obtained by averaging five consecutive traces and represent
typical observations.
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Microfluorometric Determination of
Calcium Responses
Fluorescence signal was collected from a square-shaped window
comprising the cell body of the neuron under investigation
loaded with 100 µM of the high-affinity, non-ratiometric
calcium dye Fluo4 pentapotassium salt (Molecular Probes). Two
to three minutes were usually sufficient for complete loading.
No differences in major electrophysiological parameters
were observed between dye-filled and control neurons.
Fluorescence was elicited with a 488 nm LED and collected
with a photomultiplier tube (PMT; Cairns Research) with
a 10 kHz sampling rate. LED excitation was triggered with
the electrophysiological protocol and the PMT signal was
acquired and processed as described for voltage signal. SCRs
are reported as ∆F/F0, where F0 signal was the baseline
emission of the loaded neuron at rest, and ∆F was defined
as Fpeak − F0. Background fluorescence was obtained by
measuring the emission of a Fluo 4-free area of the slice and
subtracting the obtained value from F0. Off-line analysis was
performed with Clampfit 10 (Molecular Devices) and Origin
9.1. For the analysis of SCRs kinetics, rise and decay time are
intended as the time required to reach 50% of peak. Recordings
showing F0 decay exceeding 0.5%/s within a single trial, or
undergoing irreversible F0 rise during consecutive trials were
discarded.
Reagents
Unless otherwise specified, reagents were purchased from Sigma-
Aldrich (Saint-Louis, MO, USA). AMPA, NMDA and type
1 metabotropic glutamate receptors (mGluRs) were blocked
with, respectively, NBQX, D-APV and CPCOOEt (10 µM,
50 µM, 1 µM; Tocris bioscience, Bristol, UK). GABAA–B
receptors were blocked with SR95531 and CGP55845, (10 µM,
1 µM; Tocris). T-type and L-type Voltage-Gated calcium
channels (VGCCs) were blocked with mibefradil and isradipine
(5 µM each; Tocris). Pharmacological suppression of Ih was
obtained with ZD7288 (10 µM; Tocris). Fluo 4 was purchased
from Thermo Fisher Scientific (Waltham, MA, USA). GABAB
agonist baclofen was used at 1 µM. The KATP channel blocker
glybenclamide was used at 10 µM.
In Vivo Procedures
All in vivo procedures were conducted in compliance with the
Council Directive of the European Community (2010/63/EU),
Decreto Legislativo Italiano 26 (13/03/2014) and approved by
the Animal Care Committee of the University of Florence.
Male Wistar rats (200–220 g) were purchased from Charles
River Laboratories Italia (Lecco, Italy). Animals were housed
in humidity- and temperature-controlled room (22–24◦C),
allowed free access to food (4RF21; Mucedola s.r.l., Milan,
Italy) and water, and kept on a 12-h light/dark cycle (lights
start at 7:00 AM). Procedures were performed according to
a previous report (Provensi et al., 2017), with modifications
due to the different brain areas involved. One week after
arrival, animals were anesthetized with an intraperitoneal (i.p.)
injection of 80 mg/kg zoletil plus 15 mg/kg xylazine and placed
on a stereotaxic frame (Stellar, Stoelting Co., Wood Dale, IL,
USA). A stainless steel cannula (22 gauge) was implanted
bilaterally above the SNpc-VTA boundary (anterior, −5.3 mm;
lateral, ± 2 mm; ventral, −6.6 mm from Bregma) and fixed to
the skull by using dental cement. Correct cannula placement
was verified postmortem. Animals were allowed 3 days to
recover from surgery before microinjection procedure. For
microinfusions, animals were gently restrained by hand, and an
injection needle (30 gauge) was inserted tightly into the guide
to 1 mm beyond the end of the guide cannulas. The injection
needle was connected to a 1 mL Hamilton microsyringe, and the
infusions were performed at a rate of 1 µl/60 s. The injection
needle was left in place for an additional 60 s to minimize
backflow. It was then withdrawn and placed on the other side,
where the procedure was repeated. The drugs used were ZD7288
(5 µg/µl) and Ivabradine (5 µg/µl) dissolved in saline. The
volume of the drugs infused was 2µl per side for four consecutive
days. Control groups received equal volumes of sterile saline
(0.9%). Correct cannula placement was verified by infusing a 4%
(weight/volume) methylene blue solution over 30 s (2 µl). Brains
were fixed by transcardiac perfusion 24 h after the last injection
with cold physiological saline followed by 4% (volume/volume)
paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4).
Brains were postfixed in the same solution overnight (4◦C) and
cryoprotected in 30% (weight/volume) sucrose in PB. Cannula
placements were considered correct when the spread was 1 mm3
or less from the intended infusion sites. Only data from animals
confirmed for correct cannula placement were analyzed.
Behavioral Tests
Twenty-four hours after the last injection, animals were tested
for general motor activity with a standard open field test.
Animals were positioned in a corner of an open-field arena
(w = 60 cm; h = 30 cm; d = 70 cm) and the general
motor activity was assessed in 10-min sessions. Animals were
monitored with a camera and the covered distance (in cm)
measured using a Smart 2.5 software. Animals were then
tested for the expression of motor symptoms associated to
monolateral DAergic degeneration, by measuring the number
of apomorphine-induced rotations. Briefly, animals received an
i.p. injection of apomorphine (0.5 mg/kg), then placed in a
transparent Perspex cylinder. Animals were video recorded for
30 min. An operator unaware of pharmacological treatments
counted the number of rotations.
Histological Evaluation of DAergic
Degeneration
After paraformaldehyde fixation, brains were cut with a
cryostate (Leica Microsystems, Buffalo Grove, IL, USA) to
obtain 50-µm thick coronal sections of the mesencephalon
(∼15 sections/brain). Sections were then probed with a mouse
monoclonal anti-Tyrosine Hydroxylase (anti-TH) antibody
(1:500; Boster Bio, CA, USA) and revealed with an Alexa
488-conjugated secondary antibody (1:500; Abcam, Cambridge,
UK). Images were taken with the 10× objective of an
epifluorescence microscope (Olympus BX63, Milan, Italy), then
digitally reconstructed with the CellSens Dimension software.
Quantitative analysis was performed on images of to the
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ventral half of whole sections according to a previously
published method (Gerace et al., 2014). In brief, mean
pixel intensity was measured in same-size square regions
of interest from the drug-injected and the saline-injected
areas of each brain. This value was then normalized to
the total intensity of the entire TH-positive area of the
drug-injected side and compared to corresponding value
of the contralateral, saline-injected side (×5 sections, each
brain).
Data Analysis and Statistics
Pooled data throughout the article are presented as
mean ± standard error (SEM) of ‘‘n’’ neurons/animals.
Unless otherwise specified, statistical significance was assessed
with Student’s t-Test for paired measures (Microcal Origin
9.1, Northampton, MA, USA). Graphs and multi-panel figures
were generated with Microcal Origin 9.1. Significance at the
p < 0.05, 0.01, 0.001 and 0.0001 level is indicated with ∗, ∗∗, ∗∗∗,
∗∗∗∗, respectively in figures. Examples of electrical and optical
recordings are averages of five traces for each condition and
intend to represent typical observations. Temporal summation
is expressed as 10th EPSP/1st EPSP ratio. Ih activation curves,
normalized I/V plot, fitting and determination of V1/2 were
generated with Origin 9.1 as described previously (Masi et al.,
2013).
RESULTS
Properties of Spontaneous SCRs in
DAergic Neurons In Vitro
Calcium elevations in DAergic neurons may arise from the
opening of membrane conductances as well as the mobilization
of intracellular calcium pools following activation of inositol
1-4-5 trisphosphate (IP3)-coupled receptors. mGluRs are major
mobilizers of calcium from internal stores in DAergic neurons
(Cui et al., 2007; Lüscher and Huber, 2010). In addition,
external calcium may flow in through calcium-permeable
glutamate receptors (Morikawa and Paladini, 2011) or L- and
T-type VGCCs (Dufour et al., 2014; Philippart et al., 2016).
Initial calcium elevation may, in turn, trigger Calcium-Induced
Calcium Release from specific intracellular reservoirs (Morikawa
et al., 2000). We tested the sensitivity of our experimental
setting by measuring AP-dependent or subthreshold SCRs
(Figure 1). During spontaneous discharge of APs (Figure 1B,
black trace), SCRs appeared as AP-locked positive spikes (green
trace, 2.967 ± 0.59%), with distinct rise and decay kinetics (rise,
97.99 ± 8.64 ms; decay, 153.88 ± 11.08 ms, N = 7). During
spontaneous subthreshold oscillations (Figure 1C), SCRs had
comparable amplitude (2.78 ± 0.13%), but slower kinetics (rise,
333.29 ± 19.37 ms; decay, 438.52 ± 16.43 ms, N = 5) compared
to the previous. In response to pipette-stimulated AP bursts,
fluorescence signal showed sustained elevation, due to transient
SCR summation. In contrast, somatic hyperpolarization elicited
a modest downward deflection of calcium signal followed
by a positive rebound at the end of negative current step
(Figure 1D).
FIGURE 1 | Properties of somatic calcium responses (SCRs) in whole-cell
patch clamped dopaminergic (DAergic) neurons in acute midbrain slices.
(A) Substantia Nigra pars compacta (SNpc) DAergic neuron loaded with
100 µM Fluo 4 pentapotassium salt with a whole-cell pipette (right-hand side)
5 min after patch rupture. Green box indicates the area selected for optical
signal collection. (B) Typical regular spiking (top) is associated with
stereotyped, phase-locked SCRs (bottom). (C) Subthreshold oscillatory
activity and corresponding slow SCRs. The single action potential (AP)-driven
SCR (arrow) in the example trace has faster kinetics but similar amplitude.
(D) SCRs elicited by somatic square current injection (−100/+100 pA).
Voltage-Dependent Component of Evoked
EPSP-Induced SCRs
Simultaneous recordings of evoked synaptic activity and SCRs
were obtained in DAergic neurons of the SNpc or the VTA
in acute horizontal slices prepared from P20 to P30 Wistar
rats (Figure 2). The study was restricted to neurons with
typical DAergic morphology and physiological properties (large,
polygonal or fusiform cell body, broad AP, Ih ≥ 200 pA).
Morphological and electrophysiological properties are good
predictors of DAergic phenotype in the SNpc. In the VTA,
DAergic neurons were selected on the basis of the specified
electrophysiological phenotype and their position relative to
the medial terminal nucleus of the accessory optic tract (MT;
Neuhoff et al., 2002; Margolis et al., 2006). In addition,
because in the VTA standard DAergic markers are less specific
(Margolis et al., 2010), a separate group of DAergic-like VTA
neurons were challenged with the GABAB agonist baclofen
(1 µM). The activation of an outward potassium current
following baclofen administration is a good predictor of DAergic
phenotype (Margolis et al., 2012). Eight out of nine neurons
showing a presumed DAergic phenotype (morphology, Ih ≥
200 pA) responded to baclofen (Figure 2D), thus confirming the
reliability of the selection criteria described above. It has been
demonstrated that HCN channels reduce synaptic excitability
in many neuronal types by dampening the amplitude and
duration of EPSPs (He et al., 2014). Consistently, Ih inactivation
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enhances dendritic calcium spikes in CA1 pyramidal neurons
due to increased EPSP temporal summation and T-/N-Type
VGCC recruitment (Tsay et al., 2007). However, it has not
been tested whether this phenomenon occurs in midbrain
DAergic neurons, or whether it has any significance in DAergic
pathologies. To address this question, we optimized a stimulation
paradigm producing subthreshold EPSPs and simultaneously
measured the changes in emission intensity of the high-
sensitive, non-ratiometric dye Fluo 4. Stimulation conditions
such as frequency, amplitude and duration of stimuli, and
baseline potential were adjusted as not to determine plasticity
of synaptic responses or irreversible calcium accumulation
(Jones and Bonci, 2005; Kauer and Malenka, 2007; Harnett
et al., 2009). Preliminary studies of EPSP-driven calcium signal
properties were carried out in SNpc DAergic neurons. Figure 2A
shows representative single and multiple EPSPs and associated
calcium signals elicited with protocols of increasing duration
and frequency, designed to assess the input-output properties of
our synaptic stimulation protocol. Single EPSPs (peak amplitude:
4.43 ± 0.53 mV, baseline potential: −62.75 ± 1.06 mV, n = 9)
FIGURE 2 | Voltage-dependent component of evoked excitatory post-synaptic potential (EPSP)-induced SCRs. (A) Single or multiple evoked EPSPs (black), in
absence of pharmacological isolation, and relative Fluo 4 traces (green). Traces are baseline-adjusted to facilitate comparison. Single EPSPs are not able to elicit
detectable SCRs (left). A short EPSP train (10 Hz/1 s) is able to elicit a measurable SCR (middle). Twenty hertz/two seconds stimulation protocols elicit prolonged,
slow-decaying, but not saturating, SCRs (right). (B) multiEPSP and relative SCRs recorded before (left) and after superfusion with GABAA, GABAB and metabotropic
glutamate receptors 1 (mGlu1) receptor antagonists (SR95531, 10 µM; CGP55485, 1 µM and CPCCOEt, 1 µM; middle). Subsequent administration of AMPA and
NMDA receptor antagonists (NBQX, 10 µM; D-APV, 50 µM) fully abolishes the SCR (right). Note that voltage and optical traces have different time scales. (C) The
amplitude of first EPSP does not change during 10 min of synaptic stimulation with the 10 Hz/1 s protocol in presence of GABAA–B and mGlu1 antagonists.
(D) Characterization of Ih-positive, putative DAergic neurons in the ventral tegmental area (VTA) based on the electrophysiological response to bath application of the
GABAB agonist baclofen (1 µM). The inset shows the whole-cell current in response to a −95 mV step. Eight/nine neurons showing I ≥ 200 pA responded to
baclofen. Ih-negative, presumed non-DAergic neurons do not respond to baclofen (blue traces).
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failed to elicit measurable SCRs in all neurons tested (Figure 2A,
left). Ten stimuli at 10 Hz (10 Hz/1 s) produced multiple
subthreshold EPSPs (area, 7836 ± 996 mV × ms, n = 23)
and corresponding SCRs (2.33 ± 0.53%, n = 23; Figure 2A,
middle). This response was largely below maximal level, as
a train with twice the stimulation intensity (20 Hz/2 s) was
still able to produce non-saturating SCRs (6.53 ± 1.43%,
n = 5; Figure 2A, right), although this protocol occasionally
caused progressive F0 rise, likely due to irreversible calcium
accumulation. Therefore, the 10 Hz/1 s stimulation protocol
was used for all experiments and referred to as ‘‘multiEPSP’’
henceforth throughout text and legends. In SNpc DAergic
neurons, synaptic activation of type-1 metabotropic glutamate
receptors (mGlu1) leads to the release of calcium from
intracellular stores with an IP3-mediated, Ryanodine-sensitive
mechanism (Fiorillo and Williams, 1998; Morikawa et al.,
2003). We pharmacologically eliminated this major voltage-
independent calcium response by using the mGlu1 selective
antagonist CPCOOEt (10 µM). GABAA–B receptor transmission
was also blocked with SR95531 (10 µM) and CGP55845
(1 µM) in order to isolate the AMPA/NMDA receptor-mediated
component of the multiEPSP and the corresponding SCR.
Figure 2B shows the effect of GABAA–B and mGlu1 receptor
blockers (‘‘control solution’’ henceforth) on multiEPSP and SCR.
Note that abrogation of the slow mGlu1 receptor-dependent
hyperpolarization (Fiorillo and Williams, 2000) results in the
elevation of multiEPSP area and SCR peak as shown in
an example recording (Figure 2B, middle). AMPA/NMDA
receptor blockers fully abolished both multiEPSP and SCR,
suggesting that calcium transients are sustained by activation of
NMDA receptors and VGCCs in these experimental conditions
(Figure 2B, right).We verified that the 10 Hz/1 s protocol did not
elicit forms of synaptic plasticity by monitoring the amplitude
of the first EPSP while stimulating multiEPSP for 10 min in
the control solution (Figure 2C). Figure 2D shows the response
to baclofen of 8/9 Ih-positive VTA neurons (black traces). Blue
traces refer to an Ih-negative VTA neuron which did not respond
to baclofen.
MultiEPSP-Dependent SCRs in SNpc
DAergic Neurons Are Mainly Mediated by
L-Type Calcium Channels
We sought to characterize the nature of the calcium rise triggered
by multiEPSP in SNpc DAergic neurons with a pharmacological
approach (Figure 3). We did not systematically test the
contribution of NMDA receptor activation on SCR because
NMDA receptor antagonism negatively affects EPSP kinetics
FIGURE 3 | MultiEPSP-dependent SCRs in SNpc DAergic neurons are mainly mediated by L-type calcium channels. SCRs were tested with the T- and L-type
calcium channels’ antagonists mibefradil and isradipine (5 µM, each). Both drugs are able to reduce SCRs, but only in the case of isradipine the effect achieved
statistical significance. No effect of T- and L-type calcium channels block was seen on multiEPSP (left, black traces).
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(not shown) and because it was reported that NMDA receptor-
mediated calcium transients are modest in the somatodendritic
compartment of SNpc DAergic neurons (Jang et al., 2011).
In these neurons, members of the CaV 1 and 2 families
have previously been identified as the VGCC pore-forming
subunits with activation windows in the subthreshold domain
(Chan et al., 2007; Dufour et al., 2014; Poetschke et al., 2015;
Philippart et al., 2016), thus most likely involved in calcium
inflow associated to subthreshold depolarization episodes such
as those triggered by our stimulation protocol. We tested the
involvement of T- and L-type VGCCs in multiEPSP-triggered
SCRs in SNpc DAergic neurons by using, respectively, mibefradil
(5 µM) and isradipine (5 µM). Mibefradil reduced SCR,
but the effect did not reach statistical significance (CTRL,
3.54 ± 1.17%; mibefradil, 2.39 ± 0.75%, n = 7, p = 0.177).
Isradipine, in contrast, caused a near 50%, significant reduction
of SCR (CTRL, 2.36 ± 0.48%; isradipine, 1.20 ± 0.24%; n = 8,
p = 0.014). Of note, no alteration of the amplitude or kinetics
of the multiEPSP was observed with either blocker (black
traces), suggesting a post-synaptic location of drug targets.
These results are consistent with the previously mentioned
evidence demonstrating the expression of CaV 1.2 and 1.3
L-type calcium channels in the somatodendritic compartment
of SNpc DAergic neurons, and their role at subthreshold
potentials.
Ih Block Potentiates MultiEPSP and
MultiEPSP-Dependent SCRs in SNpc
DAergic Neurons
The ability of Ih to affect multiEPSP and multiEPSP-driven
SCRs was tested using the specific blocker ZD7288 (10 µM,
10 min) in bath application (Figure 3). Prior to drug application,
multiEPSP and corresponding SCRs were recorded for 5 min in
the control solution to achieve a stable baseline. In SNpc DAergic
neurons (Figure 4A), perfusion with ZD7288 significantly
hyperpolarized the neuron (−5.117 ± 0.777 mV; n = 23,
p = 1.75 × 10−5) while increasing multiEPSP temporal
summation (CTRL, 2.165 ± 0.374; ZD7288, 3.221 ± 0.688;
n = 23, p = 0.0128) and multiEPSP area (CTRL, 7836 ± 996;
ZD7288, 14,087 ± 1473; n = 23, p = 1.63 × 10−4). Of note,
multiEPSP-driven SCR increased twofold following HCN block
FIGURE 4 | Ih block potentiates multiEPSP and multiEPSP-dependent SCR in SNpc DAergic neurons. (A) Effect of Ih block in SNpc DAergic neurons. Example of
multiEPSP in presence of GABAA–B and mGluR1 antagonists (“CTRL”) and after application of the specific Ih blocker ZD7288 (10 µM, 10 min). The expected
membrane hyperpolarization (−5.11 ± 0.77 mV) and multiEPSP area increase (top) is accompanied by potentiation of the SCR (bottom). Voltage traces are
baseline-adjusted to facilitate comparison. (B) No hyperpolarization (−0.85 ± 1.07 mV), change in multiEPSP area or SCR peak following Ih blockade in VTA DAergic
neurons. (C) Group data and statistical analysis relative to ZD7288-induced changes in multiEPSP and SCR in the two areas. (D) SCR and multiEPSP variations
caused by ZD7288 have a positive linear correlation.
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FIGURE 5 | Ih suppression depresses GABAA responses in SNpc DAergic neurons. Example of a single, pharmacologically isolated inhibitory post-synaptic potential
(IPSP) obtained with extracellular stimulation of the Substantia nigra pars reticulata (SNr) and recorded from a SNpc DAergic neuron (top). ZD7288 causes
membrane hyperpolarization accompanied by a significant reduction of peak amplitude (middle). IPSP amplitude recovers control amplitude when cell membrane is
manually held at original potential (right). Bottom, group data and statistical analysis relative to ZD7288-induced change in IPSP amplitude.
(CTRL, 2.33 ± 0.53%; ZD7288, 4.68 ± 1.32%; n = 23, p = 0.044).
In contrast, ZD7288 application did not alter membrane
potential (−0.854 ± 1.069 mV, n = 12, p = 0.445), multiEPSP
summation (CTRL, 2.819 ± 0.419; ZD7288, 3.648 ± 0.762;
n = 12; p = 0.316), and area (CTRL, 7317 ± 675; ZD7288,
8683 ± 1180; n = 12; p = 0.122), or SCR (CTRL, 3.81 ± 0.85%;
ZD7288, 2.94 ± 0.37%, n = 12, p = 0.184) in the VTA.
Comparatively, there was no significant difference in mean
multiEPSP summation, multiEPSP area or SCR amplitude
between SNpc and VTA DAergic neurons in control conditions
(p = 0.256, p = 0.69 and p = 0.16, respectively; n = 23 and 12,
two sample t Test). In presence of ZD7288, the two populations
diverged significantly in terms of magnitude of multiEPSP area
(SNpc, +110.65± 25.68%; VTA, +12.36± 13.47%, n = 23 and 12,
p = 0.0026, two sample t Test) and SCR (SNpc, +128.25 ± 34.73;
VTA, −3.87 ± 9.62%, n = 23 and 12, p = 0.0035, two sample
t Test), but not of multiEPSP summation (SNpc, 3.222 ± 0.688;
VTA, 3.647 ± 0.763, n = 23 and 12, p = 0.682, two sample
t Test). Globally, SCR increase was related to multiEPSP
area increase by a linear function (y = a + bx; a = 0.307;
b = 0.835; r = 0.641, p = 2.35 × 10−4), indicating the
strong voltage-dependent nature of SCRs. Overall, these results
indicate that Ih inhibition potentiates synaptic excitability and
depolarization-dependent somatic calcium entry. Quantitatively,
effect magnitude reaches statistical significance only in the
SNpc, consistent with the previously reported stronger influence
of Ih over synaptic excitability in this subset (Masi et al.,
2015).
Ih Suppression Depresses GABAA
Responses in SNpc DAergic Neurons
It has been shown that Ih antagonism reduces the amplitude
of GABAA-mediated IPSPs in CA1 pyramidal neurons by
hyperpolarizing the membrane potential and thus reducing
GABAA receptor driving force (Pavlov et al., 2011). We tested
whether this was also the case in SNpc DAergic neurons by
electrically stimulating GABAergic neurons in the SNr and
recording single evoked IPSPs from SNpc DAergic neurons
in presence of glutamatergic synaptic blockers (Figure 5). We
found that IPSP amplitude was significantly reduced following
bath application of ZD7288 (CTRL, −3.622 ± 0.83; ZD7288,
−2.62 ± 0.76, n = 7, p = 0.005). The effect of Ih block on IPSP
amplitude depends on the negative shift in membrane potential,
as indicated by the recovery of IPSP amplitude obtained by
offsetting the ZD7288-induced hyperpolarization. These results
indicate that Ih block increases synaptic excitability with a dual
mechanism, that is by increasing the response to excitatory inputs
and by reducing that to inhibitory inputs.
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Low Intracellular ATP Causes a Negative
Shift in Ih Activation Curve
Disruption of mitochondrial homeostasis is increasingly seen as
a fundamental pathogenic process involved in both familial and
sporadic forms of PD (Schapira and Gegg, 2011). Animal models
generated by intoxication with mitochondrial poisons, such as
MPP+, or by introduction of DAergic-targeted mitochondrial
defect, as in the case of the MitoPark model, are characterized
SNpc-specific DAergic degeneration (Ekstrand and Galter, 2009;
Blesa and Przedborski, 2014). Both models have been associated
to Ih loss of function, therefore we asked whether HCN
channels in SNpc DAergic neurons, in vitro, respond to block of
mitochondrial ATP synthesis and lowATP levels. To this aim, we
recorded Ih activation curves using a whole-cell pipette solution
containing 0mMATP and 10µMoligomycin, a selective blocker
of mitochondrial F0-F1 ATP synthase (Figure 6). Olygomicin
causes the block of mitochondrial, but not glycolytic, ATP
synthesis, leaving the transmembrane mitochondrial potential
unaffected (Nicholls and Budd, 2000; Schuchmann et al., 2000).
As a control, we used a standard K methanesulfonate-based
solution containing 2 mM ATP. Ih activation curves were
recorded immediately after patch rupture and 30 min later.
Figure 6 shows example traces (left) and activation curves (right)
obtained with control (top) and 0 ATP/oligomycin (bottom)
pipette solution. No changes in Ih activation curve was observed
with control pipette solution (V1/2 t0 = −82.25 ± 0.47 mV;
V1/2 t30 = −82.39 ± 0.73 mV; n = 5, p = 0.269). In contrast,
low ATP caused a highly-significant, negative shift in Ih
activation curve (t0, V1/2 = −82.85 ± 0.56 mV; t30, V1/2 =
−91.48 ± 0.70 mV; n = 7, p = 0.000589). Importantly, the
effect occurred in the absence of detectable changes in holding
current and membrane resistance. In one case, low ATP solution
caused the appearance of an outward current, which was fully
reverted by application of 10 µM glybenclamide, a selective
KATP channel blocker (not shown). The magnitude of the shift
in voltage dependence was consistent with the effect exerted
by changes in cAMP levels on HCN2 and HCN4 (Biel et al.,
2009), the two main Ih pore-forming subunits in SNpc DAergic
FIGURE 6 | Low intracellular ATP causes a negative shift in Ih activation curve. Top, example of voltage clamp recordings at 1 min (black) and 30 min (red) after
patch rupture with control pipette solution. Respective Ih activation curves show perfect overlap (right). Bottom, same experiment, but using a pipette solution with
0 mM ATP and 10 µM oligomycin. Ih activation curve at 30 min is left-shifted by ∼9 mV (right). Arrows indicate current traces obtained at the −85 mV test potential
to highlight the shift in voltage dependence.
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neurons (Franz et al., 2000; Dufour et al., 2014), suggesting that
impaired cAMP synthesis is the mechanism of action involved
here.
Local Pharmacological Ih Suppression
Causes Preferential SNpc DAergic
Degeneration and Hemiparkinsonism
We tested the hypothesis that Ih suppression participates
in the pathogenic cascade eventually leading to preferential
degeneration of nigrostriatal DAergic neurons. To this aim, we
performed intracerebral injections of two distinct Ih blockers
following stereotaxic coordinates in adult rats. Injection site was
1 mm above the SNpc-VTA boundary. ZD7288 and Ivabradine
(5µg/µl, 2µl each) were injected once a day for four consecutive
days on one hemisphere, while the contralateral hemisphere
was injected with an equal volume of saline. On the fifth day,
animals were first tested for spontaneous motility then for
the expression of apomorphine-induced rotation behavior, a
typical sign of monolateral nigrostriatal degeneration (Hudson
et al., 1994). As shown in Figure 7A, ZD7288- or Ivabradine-
treated animals did not show changes in spontaneous locomotion
compared to controls (ZD7288, 2511 ± 328 cm, n = 8;
Ivabradine 2982 ± 303 cm, n = 5; saline 2345 ± 216 cm,
n = 8; one way ANOVA + Newman-Keuls post hoc test,
F(2,20) = 1.098, p = 0.354, for differences among treatments).
In contrast, both treatments significantly increased the number
of apomorphine-induced rotations (ZD7288, 49 ± 9 turns in
30 min, n = 8, Ivabradine, 39 ± 15, n = 4, saline, 8 ± 2, n = 8,
p = 0.004, one way ANOVA + Newman-Keuls post hoc test,
F(2,19) = 7.671, p < 0.004 for differences among treatments;
Figure 7B). Afterwards, DAergic degeneration was assessed
by performing TH immunostaining in coronal sections from
the mesencephalon of treated and control animals. As clearly
FIGURE 7 | Local pharmacological Ih suppression causes preferential SNpc DAergic degeneration and hemiparkinsonism. Spontaneous locomotion (A) and
apomorphine-induced rotations (B) in rats after repeated monolateral infusions of ZD7288 and Ivabradine (1/day × 4 days). (C) Representative microphotographs
showing tyrosine hydroxylase (TH) immunofluorescent labeling on midbrain coronal sections. Circles indicate histologically-confirmed injection sites (scale
bar = 1 mm). (D,E) Densitometric analysis of ZD7288- and Ivabradine-induced DAergic degeneration in the SNpc and VTA.
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shown by the representative microphotographs (Figure 7C),
the intensity of TH staining is significantly decreased in the
SNpc of the drug-injected side compared to saline-injected side
(ZD7288, 75.86 ± 4%, n = 8, p = 0.001 vs. control; Ivabradine,
69.51 ± 8.9%, n = 6, p = 0.001 vs. control; Figure 7D).
In contrast, the effect of ZD7288 was much smaller in the
VTA, while Ivabradine failed to achieve statistical significance
(ZD7288, 86.91 ± 4%, n = 8, p = 0.01 vs. control; Ivabradine,
94.78 ± 7.9%, n = 6, p = 0.7 vs. control; Figure 7E). Overall,
these results suggest that Ih suppression is sufficient to cause
degeneration of DAergic neurons. Furthermore, degeneration
is not homogeneous, as SNpc DAergic neurons are strikingly
more sensitive to the effects of Ih suppression compared to VTA
DAergic neurons.
DISCUSSION
In the first part of the present work, by using whole-cell
patch clamp electrophysiology and microfluorometric calcium
measurements in rat brain slices, we demonstrate that Ih not
only determines synaptic excitability in DAergic neurons as
we previously showed (Masi et al., 2015), but also indirectly
FIGURE 8 | Conceptual scheme of the hypothetical pathogenic cascade
linking mitochondrial dysfunction, Ih loss of function and SNpc-specific
neurodegeneration during the progression of Parkinson’s disease (PD).
regulates synaptic-driven, voltage-dependent calcium entry. This
function is area-specific, as Ih pharmacological blockade causes
significant enhancement of multiEPSP and associated SCR
in the SNpc, while neither parameter is significantly affected
in the VTA. This is consistent with the differential control
exerted by Ih over synaptic excitability between the two areas
in TH-GFP mice (Masi et al., 2015). Of note, functional Ih
diversity between SNpc and VTA was quantitative in TH-GFP
mice, while it appears to be qualitative in rats, a discrepancy
which presumably results from the species difference. We
pharmacologically characterized the source of calcium recruited
by multiEPSP in SNpc DAergic neurons with the L- and T-type
VGCCs blockers isradipine and mibefradil. Only isradipine
was effective in causing a significant reduction of SCRs. This
finding does not allow discrimination between CaV 1.2 and
1.3, as the two pore-forming subunits show comparable affinity
for the drug (Zamponi et al., 2015), while the non-significant
effect produced by mibefradil indicates a limited contribution
of T-type calcium channels to SCRs, in agreement with the
relatively hyperpolarized activation window of these channels.
The contribution of an NMDA receptor-dependent calcium
component to SCRs, although possible in our experiments,
was not tested because NDMA receptor blockers alter EPSP
kinetics, thus confounding the effect of Ih blockade on dendritic
integration. Moreover, it has been shown that NMDA receptor-
dependent calcium inflow is relatively modest at proximal
dendritic locations, while VGCC-dependent calcium inflow is
relatively large, suggesting a limited contribution of the first
to SCRs, at least in quantitative terms (Jang et al., 2011). In
agreement, another study has reported strong expression of CaV
1.2, 1.3 and CaV 3.1, 3.2, 3.3 pore-forming subunits in the
somatodendritic compartment of SNpc DAergic neurons in rats
(Dufour et al., 2014). Our results imply that one physiological
function of Ih is to limit synaptic-dependent calcium entry.
Ih suppression enhances AMPA/NMDA receptor-mediated
response and blunts GABAA receptor-mediated response, thus
increasing synaptic excitability in a dual manner. In this work,
we also show that Ih is functionally regulated by intracellular
ATP concentration. Low intracellular ATP, obtained by using
a pipette solution containing 0 mM ATP and 10 µM of the
F0-F1 ATP synthase blocker oligomycin, causes a ∼ −10 mV
negative shift in Ih activation curve. This is compatible with
the reported cAMP sensitivity of HCN2 and HCN4 (Biel et al.,
2009), the two isoforms sustaining Ih in SNpc DAergic neurons
(Franz et al., 2000; Dufour et al., 2014). As there is no evidence
for a direct modulation of HCN channels by ATP, the observed
shift in the voltage dependence is likely due to reduced cAMP
synthesis. Importantly, this experiment suggests a mechanistic
link between ATP levels, Ih-dependent synaptic excitability
and calcium dynamics. In this regard, there is increasing
evidence linking mitochondrial damage to Ih function. Ih is
suppressed by the mitochondrial toxin MPP+ in vitro (Masi
et al., 2013) and lamotrigine, a commercial anticonvulsant
agent reported to activate Ih (Poolos et al., 2002; Friedman
et al., 2014), is neuroprotective in MPTP-induced DAergic
degeneration models (Archer and Fredriksson, 2000; Lagrue
et al., 2007). Furthermore, Ih current density is diminished in
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SNpc DAergic neurons of MitoPark mice at 6 weeks of age,
well before the appearance of neurodegeneration (Good et al.,
2011). This finding is consistent with the evidence, presented
here, that Ih is functionally coupled to ATP levels. Of note,
another more recent work has reported a reduction in Ih
current density in surviving DAergic neurons in a rat model
showing spontaneous α-synuclein accumulation, suggesting that
the pathogenic relevance of Ih loss of function may not be
limited to mitochondrial models (Guatteo et al., 2017). Here,
we show that local administration of Ih blockers leads to
DAergic degeneration in adult rats. Like in many established
PD models, DAergic degeneration is most severe in the SNpc,
while the VTA appears substantially spared. In view of PD
pathogenesis, Ih loss of function may possibly be regarded as
an acquired alteration, caused by disruption of mitochondrial
metabolism, affecting specifically, or to a larger extent, DAergic
neurons in the SNpc, where Ih is critical in the regulation
of synaptic excitability. SNpc DAergic neurons receive a tonic
excitatory input from the Subthalamic nucleus (STN), which is
disinhibited during PD progression as a consequence of striatal
dopamine loss. Experimental ablation of this input protects
SNpc DAergic neurons from MPTP and 6-OHDA-induced
degeneration (Piallat et al., 1996; Wallace et al., 2007), suggesting
the involvement of an excitotoxic pathogenicmechanism in these
models. Therefore, it is conceivable that STN disinhibition may
add to the excitation/inhibition unbalance caused by Ih loss of
function and eventually determine a SNpc-specific pathogenic
pathway involving L-type VGCCs activation, as schematized
in Figure 8. CaV 1.3-mediated dendritic calcium oscillations,
characterizing rhythmic activity of SNpc DAergic neurons, have
previously been suggested to determine the vulnerable phenotype
of these neurons (Guzman et al., 2009; Ilijic et al., 2011;
Surmeier and Schumacker, 2013). In agreement, clinical studies
and meta-analyses indicate that users of brain-permeable L-type
VGCC blockers have a 30% reduced risk of developing PD
(Ritz et al., 2010; Lang et al., 2015). Our results indicate that
L-type calcium channels are activated by normal subthreshold
synaptic activity and become hyperactivated in SNpc DAergic
neurons following pharmacological Ih suppression. In vivo, Ih
loss of function may result from mitochondrial dysfunction,
a key disease mechanism at the basis of extensively studied
PD animal models, which is gaining increasing attention in
the human pathology too. To conclude, the present research
supports the hypothesis that Ih loss of function represents a
bona fide pathogenic mechanism which, possibly in concert with
SNpc-specific connectivity, may determine differential DAergic
vulnerability during disease progression in relevant animal
models and in human PD.
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